Strive Financial Group’s CollPlant Biotechnologies OPHI Stock Holding History

Strive Financial Group’s Portfolio OPHI Stock Details OPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$60	Sell	16 -1	-6%	-$3	﹤0.01%	1240
2026 Q2	$59	Buy	+17	New	+$65	﹤0.01%	832

Other funds holding OPHI

St. Denis J. Villere & Co New Orleans, Louisiana $775M AUM 13.27% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Strive Financial Group's OPHI Position: Q3 2026 in Review

Strive Financial Group reduced its CollPlant Biotechnologies (OPHI) stake by 5.9% in Q3 2026, selling an estimated $3 and leaving 16 shares worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Strive Financial Group first reported a position in OPHI in Q2 2026 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

Strive Financial Group held 16 shares of CollPlant Biotechnologies worth $60 as of Q3 2026.
Strive Financial Group sold 1 CollPlant Biotechnologies share in Q3 2026, an estimated $3.
CollPlant Biotechnologies made up ﹤0.01% of Strive Financial Group's portfolio in Q3 2026, its #1240 holding.
Strive Financial Group first reported a position in CollPlant Biotechnologies in Q2 2026 and has held it in 2 quarters since.
7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on Strive Financial Group's 13F filing for Q3 2026, filed 9 Nov 2026.